RSPO3 and cholangiocarcinoma: The study observed that targeting RSPO3 promoter DNA demethylation in CCA cells QBC939 and HCCC9810 resulted in a significant decrease in their proliferative capacity, as demonstrated by the CCK-8 assay (Fig. 4J, K) and clone formation assay (Fig. 4L–N).